MedTrace Logo

Neurocognitive Functioning in Patients With Newly Diagnosed Upper Aerodigestive Tract Cancer Receiving Treatment at Henry-Joyce Cancer Clinic

NCT00533884 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 86

Last updated 2017-04-07

No results posted yet for this study

Summary

RATIONALE: Gathering information about how often problems with neurocognitive functioning occur in patients with newly diagnosed upper aerodigestive tract cancers may help doctors learn more about the disease.

PURPOSE: This clinical trial is studying neurocognitive functioning in patients with newly diagnosed upper aerodigestive tract cancers receiving treatment at Henry-Joyce Cancer Clinic.

Conditions

Interventions

OTHER

Assessment of therapy complications

Assessment of neurocognitive function, functional status, symptom prevalence and distress, and mood alterations

OTHER

Neurocognitive assessment

Assessment of neurocognitive domains: attention/concentration, executive function, verbal learning, verbal memory, verbal fluency

OTHER

Quality-of-life assessment

Assessment of quality of life using Cantrill's Ladder at baseline and 3 months post-treatment

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    collaborator NIH

  • Vanderbilt University Medical Center

    lead OTHER

Principal Investigators

  • Stewart M. Bond, PhD, RN · Vanderbilt-Ingram Cancer Center

Eligibility

Min Age
21 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-10-31
Primary Completion
2010-05-31
Completion
2013-06-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00533884 on ClinicalTrials.gov